A new neuroregulator: the vasoactive intestinal peptide or VIP
- PMID: 6290287
- DOI: 10.1016/0303-7207(82)90092-2
A new neuroregulator: the vasoactive intestinal peptide or VIP
Abstract
VIP is a neuroregulator occurring in the central and peripheral nervous system which exhibits the function of neurotransmitter in the brain, neuroendocrine substance at the pituitary level, and neuroparacrine substance in peripheral organs. The structure and the specificity of the molecule as studied by antibody and receptor, and its location in brain and peripheral organs are summarized as well as its numerous biological effects. The method used to demonstrate the involvement of VIP in a physiological regulation is described and illustrated by two examples: the effect of VIP on gut epithelium and the neuroendocrine action of VIP in inducing prolactin release from pituitary cells. The consequence of this recent progress in the knowledge of VIP release and action in human physiology and disease is indicated.
Similar articles
-
Vasoactive intestinal polypeptide: functional aspects.Br Med Bull. 1982 Sep;38(3):265-70. doi: 10.1093/oxfordjournals.bmb.a071771. Br Med Bull. 1982. PMID: 6129023 Review. No abstract available.
-
[Vasoactive intestinal peptide (VIP): specific receptors and adenylate cyclase activation in a human prolactin-secreting pituitary tumor].C R Seances Acad Sci D. 1979 May 7;288(17):1315-7. C R Seances Acad Sci D. 1979. PMID: 225051 French.
-
Vasoactive intestinal polypeptide (VIP).Med Biol. 1980 Aug;58(4):179-81. Med Biol. 1980. PMID: 7266081 No abstract available.
-
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release.Neuroendocrinology. 1990 Apr;51(4):481-6. doi: 10.1159/000125378. Neuroendocrinology. 1990. PMID: 2161088
-
The mechanisms by which vasoactive intestinal peptide (VIP) and thyrotropin releasing hormone (TRH) stimulate prolactin release from pituitary cells.Biosci Rep. 1990 Apr;10(2):189-99. doi: 10.1007/BF01116578. Biosci Rep. 1990. PMID: 2162702 Review.
Cited by
-
The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein nature.Biochem J. 1987 Feb 15;242(1):185-91. doi: 10.1042/bj2420185. Biochem J. 1987. PMID: 3036083 Free PMC article.
-
Lateralized hippocampal effects of vasoactive intestinal peptide on learning and memory in rats in a model of depression.Psychopharmacology (Berl). 2012 Jun;221(4):561-74. doi: 10.1007/s00213-011-2600-1. Epub 2011 Dec 8. Psychopharmacology (Berl). 2012. PMID: 22160165
-
Biological pathway-based genome-wide association analysis identified the vasoactive intestinal peptide (VIP) pathway important for obesity.Obesity (Silver Spring). 2010 Dec;18(12):2339-46. doi: 10.1038/oby.2010.83. Epub 2010 Apr 8. Obesity (Silver Spring). 2010. PMID: 20379146 Free PMC article.
-
Active Immunization Against Inhibin Impaired Spermatogenesis, Plasma Luteinizing Hormone, Pituitary Prolactin mRNA, and Hypothalamic Vasoactive Intestinal Peptide mRNA Expressions in Yangzhou Ganders.Vet Sci. 2025 Apr 27;12(5):413. doi: 10.3390/vetsci12050413. Vet Sci. 2025. PMID: 40431506 Free PMC article.
-
Vasoactive intestinal polypeptide increases whole pancreatic blood flow but does not affect islet blood flow in the rat.Acta Diabetol. 1994 Jun;31(2):103-6. doi: 10.1007/BF00570545. Acta Diabetol. 1994. PMID: 7949220